Aptahem AB (publ)

Stockholm Stock Exchange APTA.ST

Aptahem AB (publ) Market Capitalization on January 14, 2025: USD 1.35 M

Aptahem AB (publ) Market Capitalization is USD 1.35 M on January 14, 2025, a -56.46% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • Aptahem AB (publ) 52-week high Market Capitalization is USD 7.09 M on February 01, 2024, which is 423.76% above the current Market Capitalization.
  • Aptahem AB (publ) 52-week low Market Capitalization is USD 571.26 K on November 29, 2024, which is -57.79% below the current Market Capitalization.
  • Aptahem AB (publ) average Market Capitalization for the last 52 weeks is USD 1.70 M.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
Stockholm Stock Exchange: APTA.ST

Aptahem AB (publ)

CEO Mr. Mikael Lindstam
IPO Date April 17, 2015
Location Sweden
Headquarters Norra Vallgatan 58, 4TR
Employees 5
Sector Health Care
Industries
Pharmaceuticals Biotechnology Clinical Trials
Description

Aptahem AB (publ), a clinical stage biotechnology company, develops aptamer-based pharmaceuticals for the treatment of acute life-threatening conditions. Its principal pharmaceutical candidate is Apta-1, which is in preclinical stage to prevent mortality rate caused by organ and tissue damage in sepsis patients. The company has collaborations with various academic groups, including Consortium with Orebro University, Seattle Children's Research Institute, and University Health Network. Aptahem AB (publ) was incorporated in 2014 and is based in Malmö, Sweden.

StockViz Staff

January 15, 2025

Any question? Send us an email